About: Cardiological society of India position statement on COVID-19 and heart failure

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Cardiological society of India position statement on COVID-19 and heart failure Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Cardiological society of India position statement on COVID-19 and heart failure
Creator	Singh, B Naik, N Khanna, N Ray, S Gupta, R Gupta, V Ambuj, Roy Chakraborty, R Chandra, Sharad Chopra, H Das, M Deb, P Yadav, R Goswami, K Guha, S Hasija, P Jayagopal, P Kahali, D Katyal, V Kerkar, P Mandal, M Manish, Bansal Mathew, Cibu Mohanan, P Roy, D Tyagi, S Venugopal, K Wander, G Wardhan, Harsh Chattarjee, S Chopra, V Goswami, A Goyal, A Goyal, Deb Harikrishnan, S Jabir, A Majumder, B Meena, C Narain, V Pathak, L Pathak, La-Nanavati Sanjay, G Sarma, D Shanmugasundaram, S Sree, Harikrishnan Superspeciality,
Source	Elsevier; Medline; PMC
abstract	The COVID 19 global pandemic has engulfed humanity with a huge impact on health systems across the world. Many patients develop myocardial injury which can lead to significant cardiovascular complications including HF. This will require aggressive management strategies which are evolving. Guideline directed drug therapy including ACEI/ARB/ARNI is to be continued in patients with pre-existing HF. Long-term cardiovascular effects of COVID-19 are yet to be ascertained. Protection of health care personnel from contracting the disease should be given high priority.
has issue date	2020-05-13(xsd:dateTime)
bibo:doi	10.1016/j.ihj.2020.04.012
bibo:pmid	32405088
has license	no-cc
sha1sum (hex)	ab506440ea3a3bba8fc891913c17fd7c592b0f1f
schema:url	https://doi.org/10.1016/j.ihj.2020.04.012
resource representing a document's title	Cardiological society of India position statement on COVID-19 and heart failure
has PubMed Central identifier	PMC7219407
has PubMed identifier	32405088
schema:publication	Indian Heart J
resource representing a document's body	covid:ab506440ea3a3bba8fc891913c17fd7c592b0f1f#body_text
is schema:about of	named entity 'heart failure' named entity 'HEART FAILURE' named entity 'heart failure' named entity 'COVID-19' named entity 'HFpEF' named entity 'systolic' named entity 'anti-viral therapy' named entity 'biomarkers' named entity 'people with diabetes' named entity 'troponin' named entity 'ventricular function' named entity 'ventilatory support' named entity 'IL-6' named entity 'respiratory infection' named entity 'ejection fraction' named entity 'methylprednisolone' named entity 'Heart transplant' named entity 'drug interaction' named entity 'ADHF' named entity 'COVID' named entity 'Antiviral therapy' named entity 'Heart Failure' named entity 'venous thromboembolism' named entity 'aerosols' named entity 'hemodynamic' named entity 'ICU' named entity 'ibuprofen' named entity 'health systems' named entity 'ventricular function' named entity 'COVID -19' named entity 'serum' named entity 'sinus tachycardia' named entity 'cytokine storm' named entity 'membrane oxygenator' named entity 'inotropes' named entity 'cardiomyopathy'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software